Literature DB >> 8434294

Selection of oral controlled-release drugs: a critical decision for the physician.

R J Arnold1, D J Kaniecki.   

Abstract

Controlled-oral release dosage formulations of medications have become relatively prevalent in medicine today because of their ability to reduce noncompliance and, perhaps, to increase efficacy. However, there are many patient- and drug-related factors that may present special problems in product selection. For example, interchange of controlled-release brands that may have different absorption characteristics can result in therapeutic failure and/or toxicity. Especially in light of recent events associated with Food and Drug Administration product reviews, this paper outlines concepts that will assist physicians in making informed decisions regarding generic substitution of oral controlled-release products.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434294     DOI: 10.1097/00007611-199302000-00013

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

Review 1.  Current status of sustained release formulations in the treatment of hypertension. An overview.

Authors:  E Mutschler; H Knauf
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

Review 2.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

3.  Prescribing errors involving medication dosage forms.

Authors:  Timothy S Lesar
Journal:  J Gen Intern Med       Date:  2002-08       Impact factor: 5.128

4.  Significance of pharmaceutical excipients in prescribed medicines: a case report.

Authors:  Sandeep Maharaj; Sureshwar Pandey; Keshwar Maharaj; Meera Sharief Sheik; Sameer Dhingra
Journal:  Clin Case Rep       Date:  2014-09-04

5.  Impact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatients.

Authors:  Chia-Chen Hsu; Chia-Yu Chou; Chia-Lin Chou; Chin-Chin Ho; Tzeng-Ji Chen; Shu-Chiung Chiang; Min-Shan Wu; Sen-Wen Wang; Chung-Yuan Lee; Yueh-Ching Chou
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.